Sugimoto, Kayo <br/><br/>
Comparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma.  [electronic resource] 

 -  Oncology  2015 
 - 42-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1423-0232 
<br/><br/><label>Standard No.: </label>10.1159/000440630  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--therapeutic use<br/>Carbamates<br/>Carcinoma, Hepatocellular--epidemiology<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--blood<br/>Humans<br/>Imidazoles--therapeutic use<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Isoquinolines--therapeutic use<br/>Japan--epidemiology<br/>Liver Neoplasms--epidemiology<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--epidemiology<br/>Neoplasm Staging<br/>Oligopeptides--therapeutic use<br/>Polyethylene Glycols--therapeutic use<br/>Polymerase Chain Reaction<br/>Prognosis<br/>Pyrrolidines<br/>RNA, Viral--genetics<br/>Recombinant Proteins--therapeutic use<br/>Ribavirin--therapeutic use<br/>Simeprevir--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Valine--analogs & derivatives<br/>Viral Load<br/>alpha-Fetoproteins--analysis